While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

The tax filing season kicked off on Jan 27, with the Internal Revenue Service accepting returns. Taxpayers could face ...

The global orally disintegrating tablet market size was valued at USD 14.76 billion in 2024 and is projected to grow from USD 16.33 billion in 2025 to USD 28.88 billion by 2033, exhibiting a CAGR of 7 ...

Pasithea Therapeutics shares were up 67% to $3.46 in premarket trading after the company said that an external safety review committee recommended that its Phase 1 clinical trial of PAS-004 in ...

Pasithea Therapeutics (KTTA) announced that the external Safety Review Committee recommended that the Company’s Phase 1 clinical trial of ...

Mapping isn't a simple process in Path of Exile II. This guide will show you the best ways to create valuable map nodes and ...

This characteristic of Contramid ® permits the design of tablets that are tailored to release tramadol continuously over a 24-hour period. This new tramadol once-daily (OAD) formulation was ...

The Union Budget 2025, which will be presented on February 1, will be the second full budget of the Modi 3.0 government. This ...

Most people who are eligible for tax credits claim them. Direct File—the IRS’s online tool for filing tax returns—could get ...

Morinaga's Ramune tablets, containing 90% glucose, are a popular snack among students as a focus booster while studying. On ...

"Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.